Prosecution Insights
Last updated: April 19, 2026
Application No. 18/137,018

AESTHETIC TREATMENT SYSTEMS AND METHODS

Final Rejection §112
Filed
Apr 20, 2023
Examiner
TANNER, JOCELIN C
Art Unit
3771
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Revelle Aesthetics Inc.
OA Round
4 (Final)
72%
Grant Probability
Favorable
5-6
OA Rounds
3y 3m
To Grant
99%
With Interview

Examiner Intelligence

Grants 72% — above average
72%
Career Allow Rate
741 granted / 1034 resolved
+1.7% vs TC avg
Strong +36% interview lift
Without
With
+35.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 3m
Avg Prosecution
30 currently pending
Career history
1064
Total Applications
across all art units

Statute-Specific Performance

§101
0.8%
-39.2% vs TC avg
§103
44.7%
+4.7% vs TC avg
§102
25.1%
-14.9% vs TC avg
§112
20.1%
-19.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1034 resolved cases

Office Action

§112
DETAILED ACTION This Office Action is in response to the Amendment filed 4 March 2026. Claim(s) 1-2, 7-11, 18-35 are currently pending. The Examiner acknowledges the amendments to claim(s) 1-2, 8-11, 20, cancelled claim(s) 3-6, 12-17 and new claim(s) 21-35. Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Interpretation The claims in this application are given their broadest reasonable interpretation using the plain meaning of the claim language in light of the specification as it would be understood by one of ordinary skill in the art. The broadest reasonable interpretation of a claim element (also commonly referred to as a claim limitation) is limited by the description in the specification when 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is invoked. As explained in MPEP § 2181, subsection I, claim limitations that meet the following three-prong test will be interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph: (A) the claim limitation uses the term “means” or “step” or a term used as a substitute for “means” that is a generic placeholder (also called a nonce term or a non-structural term having no specific structural meaning) for performing the claimed function; (B) the term “means” or “step” or the generic placeholder is modified by functional language, typically, but not always linked by the transition word “for” (e.g., “means for”) or another linking word or phrase, such as “configured to” or “so that”; and (C) the term “means” or “step” or the generic placeholder is not modified by sufficient structure, material, or acts for performing the claimed function. Use of the word “means” (or “step”) in a claim with functional language creates a rebuttable presumption that the claim limitation is to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites sufficient structure, material, or acts to entirely perform the recited function. Absence of the word “means” (or “step”) in a claim creates a rebuttable presumption that the claim limitation is not to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is not interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites function without reciting sufficient structure, material or acts to entirely perform the recited function. Claim limitations in this application that use the word “means” (or “step”) are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. Conversely, claim limitations in this application that do not use the word “means” (or “step”) are not being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. This application includes one or more claim limitations that do not use the word “means,” but are nonetheless being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, because the claim limitation(s) uses a generic placeholder that is coupled with functional language without reciting sufficient structure to perform the recited function and the generic placeholder is not preceded by a structural modifier. Such claim limitation(s) is/are: Treatment device in claim 1 Actuating assembly in claim 1 Damper assembly in claim 4. Because this/these claim limitation(s) is/are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, it/they is/are being interpreted to cover the corresponding structure described in the specification as performing the claimed function, and equivalents thereof. If applicant does not intend to have this/these limitation(s) interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, applicant may: (1) amend the claim limitation(s) to avoid it/them being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph (e.g., by reciting sufficient structure to perform the claimed function); or (2) present a sufficient showing that the claim limitation(s) recite(s) sufficient structure to perform the claimed function so as to avoid it/them being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. Specification The incorporation of essential material in the specification by reference to an unpublished U.S. application, foreign application or patent, or to a publication is improper. Applicant is required to amend the disclosure to include the material incorporated by reference, if the material is relied upon to overcome any objection, rejection, or other requirement imposed by the Office. The amendment must be accompanied by a statement executed by the applicant, or a practitioner representing the applicant, stating that the material being inserted is the material previously incorporated by reference and that the amendment contains no new matter. 37 CFR 1.57(g). The attempt to incorporate subject matter into this application by reference to PCT/US2019/042871 is ineffective because the reference document is not clearly identified as required by 37 CFR 1.57(c)(2)). Claim Rejections - 35 USC § 112 The following is a quotation of the first paragraph of 35 U.S.C. 112(a): (a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention. The following is a quotation of the first paragraph of pre-AIA 35 U.S.C. 112: The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention. Claim(s) 1-2, 7-11, 18-35 are rejected under 35 U.S.C. 112(a) or 35 U.S.C. 112 (pre-AIA ), first paragraph, as failing to comply with the written description requirement. The claim(s) contains subject matter which was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the inventor(s), at the time the application was filed, had possession of the claimed invention. The amended limitations in claim 1, “a pushrod coupled to the handle and extending through the elongate member”, “a treatment device having…. a proximal portion attached to a distal portion of the pushrod” do not appear to be supported in the instant specification. In paragraph [0062], a pushrod (456) is discussed and references Figs. 4O-Q. The specification and drawings do not disclose or show that the pushrod extends through the elongate member (402) or that the treatment device has a proximal portion attached to a distal portion of the pushrod. The limitation in new claims 20, 28 and 29, “the second link shields the blade in the second configuration”, does not appear to be supported in the instant specification. In paragraph [0065] of the specification, the blade is disclosed as being covered or undeployed but the specification does not state or show that the second link shields or covers the blade. Fig. 4Q is referenced in paragraph [0065] and does not show the blade. Figs. 2 and 3B display the blade do not show a second link which covers or shields the blade. The limitation in new claim 21, “a pushrod coupled to the handle and extending through the elongate member”, does not appear to be supported in the instant specification. In paragraph [0062], a pushrod (456) is discussed and references Figs. 4O-Q. The specification and drawings do not disclose or show that the pushrod extends through the elongate member (402). The limitation in claim 26, “a treatment device having…. a proximal portion attached to a distal portion of the pushrod” does not appear to be supported in the instant specification. In paragraph [0062], a pushrod (456) is discussed and references Figs. 4O-Q. The specification and drawings do not disclose or show a distal portion of the pushrod being connected or attached to a proximal portion of the treatment device. The limitations in new claim 31, “a pushrod coupled to the handle and extending through the elongate member” and “the first link is attached to the distal portion of the elongate member, the second link is attached to a distal portion of the pushrod” do not appear to be supported in the instant specification. In paragraph [0062], a pushrod (456) is discussed and refers to Figs. 4O-Q. The specification and drawings do not disclose or show that the pushrod extends through the elongate member (402). Fig. 3B shows the first and second links of the treatment device but does not show that the second link is attached to the distal portion of the pushrod nor does the specification discuss the respective attachments or connections. Response to Arguments Applicant's arguments filed 4 March 2026 have been fully considered but they are not persuasive in view of the incorporation of essential material in the specification by reference is to an unpublished U.S. application, foreign application or patent or to a publication which is improper. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Park (3,704,711) discloses a catheter including a blade/treatment device (18) having a proximal portion coupled to a pushrod (20) and a distal portion attached to a distal portion of an elongate member. THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to JOCELIN C TANNER whose telephone number is (571)270-5202. The examiner can normally be reached M-F 8am-4pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jackie Ho can be reached at (571)272-4696. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JOCELIN C TANNER/Primary Examiner, Art Unit 3771
Read full office action

Prosecution Timeline

Apr 20, 2023
Application Filed
Mar 07, 2025
Non-Final Rejection — §112
Jun 13, 2025
Response Filed
Jul 25, 2025
Final Rejection — §112
Sep 29, 2025
Request for Continued Examination
Oct 01, 2025
Response after Non-Final Action
Nov 01, 2025
Non-Final Rejection — §112
Mar 04, 2026
Response Filed
Mar 27, 2026
Final Rejection — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12599397
THROMBUS REMOVAL SYSTEMS AND ASSOCIATED METHODS
2y 5m to grant Granted Apr 14, 2026
Patent 12589024
OCULAR DELIVERY SYSTEMS AND METHODS
2y 5m to grant Granted Mar 31, 2026
Patent 12582433
THROMBUS REMOVAL SYSTEMS AND ASSOCIATED METHODS
2y 5m to grant Granted Mar 24, 2026
Patent 12582437
NEEDLE AND ASSEMBLY OF NEEDLE, GUIDEWIRE, AND/OR CATHETER INSERT
2y 5m to grant Granted Mar 24, 2026
Patent 12582816
SYSTEMS AND METHODS FOR EXTRACTING AN ELECTRODE LEAD
2y 5m to grant Granted Mar 24, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

5-6
Expected OA Rounds
72%
Grant Probability
99%
With Interview (+35.8%)
3y 3m
Median Time to Grant
High
PTA Risk
Based on 1034 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month